Trade Summary

6 days ago, Hyep Ivan, serving as Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 9,200 shares at $20.42 per share, for a total transaction value of $187,883.32. Following this transaction, Hyep Ivan now holds 145,355 shares of BCAX.

This sale represents a 5.95% decrease in Hyep Ivan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 21, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 26, 2026 at 5:48 PM ET, 5 days after the trade was made.

Bicara Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.